ES8705453A1 - Un procedimiento para la preparacion de derivados de cefalosporina. - Google Patents

Un procedimiento para la preparacion de derivados de cefalosporina.

Info

Publication number
ES8705453A1
ES8705453A1 ES548774A ES548774A ES8705453A1 ES 8705453 A1 ES8705453 A1 ES 8705453A1 ES 548774 A ES548774 A ES 548774A ES 548774 A ES548774 A ES 548774A ES 8705453 A1 ES8705453 A1 ES 8705453A1
Authority
ES
Spain
Prior art keywords
group
cephalosporin derivatives
solvate
yes
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES548774A
Other languages
English (en)
Other versions
ES548774A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP60171838A external-priority patent/JPH06102668B2/ja
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Publication of ES8705453A1 publication Critical patent/ES8705453A1/es
Publication of ES548774A0 publication Critical patent/ES548774A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE CEFALOSPORINA, DE FORMULA (I), Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, ESTERES Y SOLVATOS. COMPRENDE LA REACCION DE UN COMPUESTO DE FORMULA (II) O UNA DE SUS SALES, CON UNA AMINA DE FORMULA (III), EN UN DISOLVENTE ORGANICO, A UNA TEMPERATURA COMPRENDIDA ENTRE C30JC Y 35JC PARA OBTENER EL COMPUESTO DE FORMULA (I), EN LAS QUE R1-R11 PUEDEN SER VARIOS TIPOS DE RADICALES, X ES HALOGENO O GRUPO SALIENTE E Y ES AZUFRE O SO. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SUS PROPIEDADES ANTIBACTERIANAS.
ES548774A 1984-11-12 1985-11-11 Un procedimiento para la preparacion de derivados de cefalosporina. Expired ES8705453A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23679684 1984-11-12
JP60171838A JPH06102668B2 (ja) 1985-08-06 1985-08-06 新規セフアロスポリン誘導体

Publications (2)

Publication Number Publication Date
ES8705453A1 true ES8705453A1 (es) 1987-05-01
ES548774A0 ES548774A0 (es) 1987-05-01

Family

ID=26494422

Family Applications (2)

Application Number Title Priority Date Filing Date
ES548774A Expired ES8705453A1 (es) 1984-11-12 1985-11-11 Un procedimiento para la preparacion de derivados de cefalosporina.
ES556786A Expired ES8707541A1 (es) 1984-11-12 1986-06-25 Un procedimiento para la preparacion de derivados de cefalosporina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES556786A Expired ES8707541A1 (es) 1984-11-12 1986-06-25 Un procedimiento para la preparacion de derivados de cefalosporina

Country Status (7)

Country Link
US (1) US4742053A (es)
EP (1) EP0182210B1 (es)
KR (1) KR930005588B1 (es)
CN (1) CN1008738B (es)
CA (1) CA1276140C (es)
DE (1) DE3581891D1 (es)
ES (2) ES8705453A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA877987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
DE3750673T2 (de) * 1986-11-21 1995-03-16 Ici Pharma Cephalosporine, Verfahren zu ihrer Herstellung und pharmazeutische Präparate.
ATE131824T1 (de) * 1987-07-23 1996-01-15 Zeneca Pharma Sa Cephalosporinverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische präparate
GB8816519D0 (en) * 1987-07-23 1988-08-17 Ici Plc Antibiotic compounds
DE3854684T2 (de) * 1987-07-23 1996-03-28 Zeneca Pharma Sa Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate.
US5232918A (en) * 1987-07-23 1993-08-03 Imperial Chemical Industries Plc Cephalosporin derivatives
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
NO903360L (no) * 1989-08-11 1991-02-12 Ici Pharma Antibiotiske forbindelser.
ES2147721T3 (es) * 1990-04-18 2000-10-01 Procter & Gamble Pharma Quinolonil lactamas antimicrobianas.
US5126336A (en) * 1990-08-23 1992-06-30 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
US5194433A (en) * 1990-11-13 1993-03-16 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
EP0544166A3 (en) * 1991-11-26 1993-11-03 Hoffmann La Roche Cephalosporinderivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4457929A (en) * 1982-03-29 1984-07-03 Bristol-Myers Company 3-Quaternary ammonium methyl)-substituted cephalosporin derivatives
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins

Also Published As

Publication number Publication date
KR860004067A (ko) 1986-06-16
ES556786A0 (es) 1987-08-01
EP0182210A2 (en) 1986-05-28
EP0182210B1 (en) 1991-02-27
DE3581891D1 (de) 1991-04-04
EP0182210A3 (en) 1987-08-12
CN1008738B (zh) 1990-07-11
ES548774A0 (es) 1987-05-01
KR930005588B1 (ko) 1993-06-23
CN85109545A (zh) 1986-07-23
CA1276140C (en) 1990-11-13
US4742053A (en) 1988-05-03
ES8707541A1 (es) 1987-08-01

Similar Documents

Publication Publication Date Title
ES8705453A1 (es) Un procedimiento para la preparacion de derivados de cefalosporina.
ES8202546A1 (es) Metodo de producir derivados de tiazolidina
ATE56454T1 (de) Cephalosporinderivate.
PL292101A1 (en) Method of obtaining novel derivatives of cyclopentylpurine and cyclopentylpyrimidine
AU591640B2 (en) Quinolonecarboxylic acid derivatives
EP0241901A3 (en) Cephalosporin derivatives, processes for their preparation and antibacterial agents
ATE161848T1 (de) Glycyrrheticsäurederivate
ES8503686A1 (es) Procedimiento de preparar derivados de penicilina.
PT83104B (en) Novel guanidinomethylbenzoic acid derivatives
IE40511L (en) Pyridyl piperidine derivatives
ES8704932A1 (es) Procedimiento para preparar un derivado de acido quinoloncarboxilico
ES8606330A1 (es) Procedimiento para preparar derivados de acidos quinolincar-boxilicos
ES8707245A1 (es) Un metodo para preparar nuevos derivados de cefem
EP0408044A3 (en) Anti-inflammatory and/or anti-allergic composition comprising glutathione derivatives
NZ225022A (en) Substituted ergoline derivatives and pharmaceutical compositions
ES474367A1 (es) Procedimiento de preparacion de nuevos derivados del benzo- (d)tiazol.
ES2058458T3 (es) Inhibidor de la formacion de la placa dental.
ES8505375A1 (es) Un procedimiento para obtener esteres de cefalosporina
AU2014188A (en) Naphthothiazepine derivatives and preparation thereof
AU2742288A (en) Novel compound effective as cerebral insufficiency improver
GB1510765A (en) Piperidine derivatives of indole
MY102089A (en) Antibacterial compounds.
JPS5615291A (en) Oxacephamycin derivative, its preparation, and antibacterial agent consisting mainly of it
JPS53124262A (en) Methylenomycin a derivatives and their preparation
ES8203908A1 (es) Un procedimiento para preparar un compuesto de cefalosporina